LA County will require 'superbug' reports

A new law in California will require hospitals in Los Angeles County to report incidence of certain “superbugs,” the Los Angeles Times reported. California is one of roughly half the U.S. states that had not required the reporting in the past.

The infection is caused by a bacteria known as carbapenem-resistant enterobacteriaceae and kills up to half the people who contract it. But an L.A. Times report earlier in the week showed that CDC estimates of its incidence of 75,000 per year were low due to hospital underreporting. The report also found that when patients died of the bacterial infection, physicians listed the patients’ original illness as cause of death on death certificates, further blurring accurate counts.

The county had stopped requiring reporting of the bug in 2012.

Regulators hope increasing reporting will help track the spread of such infections better and provide insight on how to prevent or slow them. Los Angeles County is noted as a particularly high-incidence area for the bug.

Check out the L.A. Times to follow one patient’s experience with a carbapenem-resistant enterobacteriaceae infection. 

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.